ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Health Disparities Center Describes “Think Tank” Projects For Policy Change.

April 27, 2001

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

More Bad News for AVEO As Tivozanib Partner Bids Adieu

May 31, 2013

DCPC To Merge Two Programs, Reorganizes Chemoprevention

November 4, 1994

NCI Grants Funding: New Funds Moved Into R01s, other Extramural Priorities

December 12, 1997

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992